Table 1 Clinical and laboratory characteristics of participants with Kawasaki disease, febrile and healthy controls
Participants’ characteristics | Complete KD (n = 39) | Incomplete KD (n = 51) | Febrile controls (n = 18) | Healthy controls (n = 20) | P-value |
|---|---|---|---|---|---|
Median age (range)/ years | 3.9 (± 2.1) | 2.6 (± 2.8) | 5.3 (± 3.4) | 6.2 (± 3.5) | 0.01 |
Gender, n (%) | |||||
Male | 24 (62%) | 36 (70%) | 8 (44%) | 8 (40%) | 0.3 |
Female | 15 (38%) | 15 (30%) | 10 (56%) | 12 (60%) | |
Duration of fever before diagnosis (mean ± SD) / days | 7.44 ± 4.52 | 13.88 ± 11.34 | N/A | NA | N/A |
WBC count, × 109/L | 13.7 (± 5.6) | 17.3 (± 15.0) | NA | NA | 0.1 |
Platelet count, × 109/L | 394 (± 153) | 750 (± 798) | NA | NA | 0.008 |
Hemoglobin, mg/dL | 10.9 (± 1.0) | 10.1 (± 1.2) | NA | NA | 0.002 |
CRP, mg/dL | 101.8 (± 68.5) | 65.7 (± 55.5) | NA | NA | 0.007 |
ESR, mm/h | 67.7 (± 27.5) | 72.7 (± 35.2) | NA | NA | 0.5 |
ALT, IU/L | 73.0 (± 85.1) | 30.0 (± 34.9) | NA | NA | 0.002 |
AST, IU/L | 47.5 (± 54.5) | 38.8 (± 51.1) | NA | NA | 0.4 |
ALP | 537.4 (± 270.0) | 368.5 (± 120.5) | NA | NA | < 0.001 |
Serum Alb | 3.9 (± 0.4) | 3.9 (± 0.6) | NA | NA | 0.7 |
cTnI, ng/ml | 0.20 (± 0.12) | 0.21 (± 0.14) | 0.13 (± 0.05) | 0.13 (± 0.02) | 0.008 |
cTnT, pg/ml | 15.00 (± 22.7) | 19.0 (± 27.8) | 3.3 (± 1.1) | 3.7 (± 1.2) | 0.1 |
CPK-MB, IU/L | 21.7 (± 9.4) | 27.70 (± 15.8) | 22.1 (± 6.7) | 26.6 (± 11.6) | 0.09 |